Ad
related to: ranbaxy labs
Search results
Results From The WOW.Com Content Network
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. The company went public in 1973.
[13] [14] [10] Ranbaxy Laboratories Limited previously experienced various issues in their attempts to produce 100 mg secobarbital capsules. In 2017, secobarbital was made available for physician-assisted suicide in Canada. [15] Animal. It is a component in the veterinary drug Somulose, used for euthanasia of horses and cattle.
The company was founded in 1995 by brothers Shivinder Mohan Singh and Malvinder Mohan Singh as Specialty Ranbaxy Limited (SRL), a 50:50 joint venture between Ranbaxy Laboratories and US-based Specialty Laboratories. [5] [6] It became the first pathology company in India to receive accreditation from National Accreditation Board. [7]
For premium support please call: 800-290-4726 more ways to reach us
Malvinder Mohan Singh is the grandson of Bhai Mohan Singh, who bought Ranbaxy Laboratories from its original founders in 1952. [7]Singh and his brother, Shivinder, attended the Doon School in Dehradun and later St. Stephen's College in Delhi.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Volini is a brand of pain relief medical spray and cream manufactured, marketed and sold by Sun Pharma in India. [1] [2] The product was created by Ranbaxy Laboratories, but has been owned by Sun Pharma ever since Ranbaxy was acquired by the latter in 2014. [3]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!